Viewing Study NCT00542269


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-02-06 @ 9:36 AM
Study NCT ID: NCT00542269
Status: TERMINATED
Last Update Posted: 2011-05-24
First Post: 2007-10-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension With Metabolic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypertension View
None Metabolic Syndrome View
None Dual combination therapy View
None Triple combination therapy View
None Aliskiren View
None Direct Renin inhibitor View